• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    1/4/23 12:11:54 PM ET
    $ARQQ
    $CANF
    $CEI
    $CTV
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ARQQ alert in real time by email

     

    On Wednesday, 35 companies reached new 52-week lows.

    Significant Points From Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Rivian Automotive (NASDAQ:RIVN).
    • The smallest company on a market cap basis to set a new 52-week low was SCWorx (NASDAQ:WORX).
    • Vera Therapeutics (NASDAQ:VERA) saw the most pronounced move, as shares traded down 60.93% to hit its new 52-week low.
    • Forward Industries (NASDAQ:FORD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    These stocks set new 52-week lows on Wednesday:

    • Rivian Automotive (NASDAQ:RIVN) shares hit a yearly low of $16.56. The stock was down 1.67% on the session.
    • TIM (NYSE:TIMB) shares reached a new 52-week low of $10.66 on Wednesday morning, moving up 0.47%.
    • GameStop (NYSE:GME) shares set a new yearly low of $16.90 this morning. The stock was down 1.16% on the session.
    • Ginkgo Bioworks Holdings (NYSE:DNA) stock set a new 52-week low of $1.45 on Wednesday, moving down 6.33%.
    • Lithium Americas (NYSE:LAC) shares fell to $17.57 on Wednesday, setting a new 52-week low with a shift of down 0.84%.
    • AMTD Digital (NYSE:HKD) shares reached a new 52-week low of $9.39 on Wednesday morning, moving up 1.63%.
    • Enovix (NASDAQ:ENVX) shares made a new 52-week low of $6.50 on Wednesday. The stock was down 44.64% for the day.
    • Laredo Petroleum (NYSE:LPI) shares fell to $46.70 on Wednesday, setting a new 52-week low with a shift of down 2.33%.
    • Overstock.com (NASDAQ:OSTK) shares hit a yearly low of $17.05. The stock was down 8.42% on the session.
    • Ring Energy (AMEX:REI) stock hit $2.14 on Wednesday morning, setting a new 52-week low for a change of down 1.79%.
    • Ramaco Resources (NASDAQ:METC) stock hit $8.12 on Wednesday morning, setting a new 52-week low for a change of down 1.66%.
    • Arqit Quantum (NASDAQ:ARQQ) shares set a new yearly low of $2.87 this morning. The stock was down 0.83% on the session.
    • Seer (NASDAQ:SEER) shares moved down 18.63% on Wednesday to hit a new 52-week low of $4.66, drifting down 18.63%.
    • Vera Therapeutics (NASDAQ:VERA) shares set a new 52-week low of $6.82. The stock traded down 60.93%.
    • Innovid (NYSE:CTV) stock achieved a new 52-week low on Wednesday morning, hitting $1.05 and moving down 25.0%.
    • D-Wave Quantum (NYSE:QBTS) stock hit a yearly low of $1.33. The stock was down 6.94% for the day.
    • Xeris Biopharma Holdings (NASDAQ:XERS) stock hit a new 52-week low of $1.05. The stock was down 6.25% on the session.
    • First Savings Financial (NASDAQ:FSFG) shares made a new 52-week low of $19.91 on Wednesday. The stock was down 0.2% for the day.
    • SeaStar Medical Holding (NASDAQ:ICU) stock hit a yearly low of $3.53. The stock was up 3.98% for the day.
    • Upexi (NASDAQ:UPXI) shares moved down 3.65% on Wednesday to hit a new 52-week low of $2.53, drifting down 3.65%.
    • Zenvia (NASDAQ:ZENV) shares fell to $1.01 on Wednesday, setting a new 52-week low with a shift of up 1.89%.
    • Camber Energy (AMEX:CEI) shares were down 3.17% for the day, having made a 52-week low of $1.80.
    • Can Fite Biofarma (AMEX:CANF) stock broke to a new 52-week low of $0.55 on Wednesday. Shares of the company traded down 3.13%.
    • Forward Industries (NASDAQ:FORD) stock set a new 52-week low of $1.01 on Wednesday, moving 0.0% (flat).
    • Oriental Culture Holding (NASDAQ:OCG) stock broke to a new 52-week low of $0.45 on Wednesday. Shares of the company traded down 16.3%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Wednesday of $0.78. Shares traded down 8.93%.
    • Novo Integrated Sciences (NASDAQ:NVOS) shares moved down 7.78% on Wednesday to hit a new 52-week low of $0.16, drifting down 7.78%.
    • SCWorx (NASDAQ:WORX) shares reached a new 52-week low of $0.37 on Wednesday morning, moving down 2.62%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ARQQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARQQ
    $CANF
    $CEI
    $CTV

    CompanyDatePrice TargetRatingAnalyst
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Ramaco Resources Inc.
    $METC
    1/20/2026$30.00Hold → Buy
    Jefferies
    Rivian Automotive Inc.
    $RIVN
    1/14/2026$15.00Neutral → Sell
    UBS
    Rivian Automotive Inc.
    $RIVN
    1/12/2026Peer Perform → Underperform
    Wolfe Research
    More analyst ratings

    $ARQQ
    $CANF
    $CEI
    $CTV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Chakravarthy Arthi covered exercise/tax liability with 2,221 shares, decreasing direct ownership by 0.55% to 404,856 units (SEC Form 4)

    4 - Enovix Corp (0001828318) (Issuer)

    2/26/26 6:08:06 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Chief Medical Officer Brenner Robert sold $90,307 worth of shares (2,151 units at $41.98), decreasing direct ownership by 4% to 50,947 units (SEC Form 4)

    4 - Vera Therapeutics, Inc. (0001831828) (Issuer)

    2/25/26 8:01:07 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R sold $130,864 worth of shares (3,117 units at $41.98), decreasing direct ownership by 5% to 64,722 units (SEC Form 4)

    4 - Vera Therapeutics, Inc. (0001831828) (Issuer)

    2/25/26 8:00:18 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARQQ
    $CANF
    $CEI
    $CTV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ARQQ
    $CANF
    $CEI
    $CTV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Rivian Automotive downgraded by DA Davidson with a new price target

    DA Davidson downgraded Rivian Automotive from Neutral to Underperform and set a new price target of $14.00

    2/17/26 7:28:03 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Rivian Automotive upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Rivian Automotive from Hold to Buy and set a new price target of $23.00

    2/13/26 10:14:02 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $ARQQ
    $CANF
    $CEI
    $CTV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit

    Four Orange Book Listed Patents through March 2040 Orphan Drug Exclusivity through December 2028 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, announced that its subsidiaries, Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, have filed a patent infringement lawsuit under the Hatch-Waxman Act related to Recorlev® (levoketoconazole) in the United States District Court for the District of New Jersey against Torrent Pharmaceuticals Limited (along with its affiliate) and Somerset Therapeutics, LLC (along with its affiliat

    2/26/26 5:55:00 PM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

    REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously adopted a tax benefit preservation plan ("NOL Plan") designed to help preserve and protect Seer's valuable income tax net operating loss carryforwards and other tax assets ("NOLs"). As of December 31, 2025, Seer had approximately $262 million of NOLs. These NOLs, most of which are not currently subject to any expiration date, represent a valuable asset of Seer and are available to reduce Seer's future federal income tax expense. The NOL Plan is similar to those adopted by numerous o

    2/26/26 4:06:00 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ARQQ
    $CANF
    $CEI
    $CTV
    SEC Filings

    View All

    Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    2/26/26 9:56:36 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-K filed by Vera Therapeutics Inc.

    10-K - Vera Therapeutics, Inc. (0001831828) (Filer)

    2/26/26 5:25:11 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Ginkgo Bioworks Holdings Inc.

    S-8 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    2/26/26 4:49:34 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ARQQ
    $CANF
    $CEI
    $CTV
    Leadership Updates

    Live Leadership Updates

    View All

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Greenwave Announces Appointment of Chelsea Pullano as Chief Financial Officer

    Chesapeake, VA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that the board of directors ("Board") of the Company appointed Chelsea Pullano as Chief Financial Officer of the Company, effective February 5, 2026. Ms. Pullano's appointment is in connection with the Company's entry into the scope of work agreement with MACK Financial Solutions, LLC ("MACK"), dated January 2, 2026, pursuant to which MACK agreed to provide professional services to the Company, including oversight of all bookkeeping, financial reporting and SEC r

    2/10/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer

    BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Matt Skelton to Chief Commercial Officer, effective immediately. Mr. Skelton joined Vera Therapeutics over a year ago as the Executive Vice President, Commercial. "We are pleased to welcome Matt to the executive team as we prepare for the potential commercial launch of atacicept for the treatment of IgA nephropathy," said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. "With his track record

    1/28/26 7:30:00 AM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARQQ
    $CANF
    $CEI
    $CTV
    Financials

    Live finance-specific insights

    View All

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

    REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously adopted a tax benefit preservation plan ("NOL Plan") designed to help preserve and protect Seer's valuable income tax net operating loss carryforwards and other tax assets ("NOLs"). As of December 31, 2025, Seer had approximately $262 million of NOLs. These NOLs, most of which are not currently subject to any expiration date, represent a valuable asset of Seer and are available to reduce Seer's future federal income tax expense. The NOL Plan is similar to those adopted by numerous o

    2/26/26 4:06:00 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

    REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights Generated revenue of $4.2 million for the fourth quarter of 2025 and $16.6 million for the full year 2025Expanded installed base to 82 instruments, representing 67% year-over-year growth, with 33 total instruments installed during the full year 2025Seminal customer studies published in Nature and Nature Genetics highlighting the power of the Proteograph to enable clinically relevant biomarker discovery and deep biologic insigh

    2/26/26 4:05:00 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ARQQ
    $CANF
    $CEI
    $CTV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials